Table 1.
Antimicrobial resistance profiles of the Salmonella isolates
| Antimicrobial agents | Salmonella enterica (n = 54) | ||
|---|---|---|---|
| No. (%) of R | No. (%) of I | No. (%) of S | |
| Macrolides | |||
| Azithromycin (AZM) | 5 (9.26) | 3 (5.56) | 46 (85.18) |
| Erythromycin (ERY) | 4 (7.41) | 1 (1.85) | 49 (90.74) |
| Aminoglycosides | |||
| Gentamicin (GEN) | 10 (18.52) | 5 (9.26) | 39 (72.22) |
| Kanamycin (KAN) | 29 (53.70) | 3 (5.56) | 22 (40.74) |
| Streptomycin (SM) | 15 (27.78) | 2 (3.70) | 37 (68.52) |
| Quinolones | |||
| Ciprofloxacin (CIP) | 5 (9.26) | 2 (3.70) | 47 (87.04) |
| Nalidixic acid (NA) | 7 (12.96) | 4 (7.41) | 43 (79.63) |
| β‐lactams | |||
| Amoxicillin (AMC) | 20 (37.04) | 2 (3.70) | 32 (59.26) |
| Ampicillin (AMP) | 32 (59.26) | 3 (5.56) | 19 (35.18) |
| Cephazolin (CEP) | 21 (38.89) | 4 (7.41) | 29 (53.70) |
| Penicillin (PEN) | 18 (33.33) | 2 (3.70) | 34 (62.97) |
| Piperacillin (PIP) | 16 (29.63) | 5 (9.26) | 33 (61.11) |
| Tetracyclines | |||
| Minocycline (MIN) | 17 (31.48) | 5 (9.26) | 32 (59.26) |
| Tetracycline (TET) | 23 (42.59) | 1 (1.85) | 30 (55.56) |
Abbreviations: I, intermediate resistance; R, resistant; S, susceptibility.